Report Id: PCCM0320
3D Cell Culture Market Size by Application (Clinical Applications, Tissue Engineering, Drug Discovery, Other Applications), By End User (Biotechnology and Pharmaceutical Companies, Research Laboratories and Institutes, Other End Users), By Product (Scaffold-Free 3D Cell Cultures, Microchips, Scaffold-Based 3D Cell Cultures), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The global 3D cell culture market size is projected to reach US$ 2773 million in 2028 at a CAGR of 15.5%.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Kirkstall LTD
- Mimetas BV
- Tissuse GmbH
- Synthecon Incorporated
- QGEL SA
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
15
REPORT DESCRIPTION
3D cell culture is a measured pretend environment exterior of a living organism, where cells are acceptable to raise and migrate by interacting within their habitat. 3D cell culture nurtures levels of cell differentiation and tissue organization which is not viable in traditional 2D culture systems. 3D cell culture has more flesh divergence and cell cohesion properties. 3D cell structures are fast popularity and have shown improved applications, specifically in the early drug discovery and other research and development. This technique is used by investigators to fabricate physiologically similar cell culture stereotypes which support drug discovery and development. Persistent need to improve efficiency in pharmaceutical research and development is also inspiring the use of 3D cell cultures. 3D cell culture is one of the rapidly rising segments in the health care space owing to considerable range of applications in cancer research, in vitro environment, and regenerative medicine. The ability of 3D cell culture to support the understanding of tissue maturation and organization, organogenesis, and cell differentiation has improved its utility. It has also changed animal prototypes in clinical testing and experiments, as these look similar to cells in vivo. Rise in adoption of 3D cell culture in diagnostic centers, hospitals, and pharmaceutical and biotech companies, and increase in demand in organ transplantation, tissue regeneration, and regenerative medicine. The main drivers of the 3D cell culture market. Researchers are conducting experiments to fee and grow better options for culturing cells, and 3D cell culturing presents various benefits like gaining better information and serving to conduct better research. 3D cell structures are relatively thicker. Hereafter, these could experience some potential barriers. Cells could react and develop differently in 3D cell culture environment. This would involve changes in experiments.
The global 3D cell culture market size is projected to reach US$ 2773 million in 2028 at a CAGR of 15.5%.
The global 3D Cell Culture market is segregated on the basis of Application as Clinical Applications, Tissue Engineering, Drug Discovery, and Other Applications. Based on End User the global 3D Cell Culture market is segmented in Biotechnology and Pharmaceutical Companies, Research Laboratories and Institutes, and Other End Users. Based on Product the global 3D Cell Culture market is segmented in Scaffold-Free 3D Cell Cultures, Microchips, Scaffold-Based 3D Cell Cultures, and Others.
The global 3D Cell Culture market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The 3D Cell Culture market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Kirkstall, LTD., Mimetas BV, Tissuse GmbH, Synthecon Incorporated, QGEL SA, Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group, Reprocell, and others are among the major players in the global 3D Cell Culture market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The 3D Cell Culture Market has been segmented as below:
3D Cell Culture Market, By Application
- Clinical Applications
- Tissue Engineering
- Drug Discovery
- Other Applications
3D Cell Culture Market, By End User
- Biotechnology and Pharmaceutical Companies
- Research Laboratories and Institutes
- Other End Users
3D Cell Culture Market, By Product
- Scaffold-Free 3D Cell Cultures
- 3D Bioreactors
- Others
- Microchips
- Scaffold-Based 3D Cell Cultures
- Hydrogels/ECM Analogs
- Others
- Others
3D Cell Culture Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
3D Cell Culture Market, By Company
- Kirkstall, LTD.
- Mimetas BV
- Tissuse GmbH
- Synthecon Incorporated
- QGEL SA
- Thermo Fisher Scientific
- Corning Incorporated
- Merck KGaA
- Lonza Group
- Reprocell
- 3D Biotek LLC
- Emulate, Inc.
- CN Bio Innovations Limited
- Hamilton Company
- Insphero AG
The report covers:
- Global 3D Cell Culture market sizes from 2022 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global 3D Cell Culture market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global 3D Cell Culture market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global 3D Cell Culture market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global 3D Cell Culture market share. Major industry players with significant revenue share include Kirkstall, LTD., Mimetas BV, Tissuse GmbH, Synthecon Incorporated, QGEL SA, Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group, Reprocell, and others.
Reasons to Buy this Report:
- Gain detailed insights on the 3D Cell Culture industry trends
- Find complete analysis on the market status
- Identify the 3D Cell Culture market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Some of the recent Developments in 3D Cell Culture market are as follows:
Kirkstall, LTD.
- 05-2020: Animal Free Research UK is initiation a Rapid Response Grant Call to explore new ideas in animal free research that directly relate to ongoing COVID-19 Research. In collaboration with Kirkstall Ltd Animal Free Research UK are proud to be offering 5 separate grants.
MIMETAS
- 08-2017: MIMETAS, in association with the pharmaceutical company Roche, has developed a novelorgan-on-a-chip system which help evaluation of intestinal permeability in perfused 3D gut tubules in high throughput.
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. 3D Cell Culture Market, By Application
5.1 Introduction
5.2 Clinical Applications
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Tissue Engineering
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Drug Discovery
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Other Applications
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. 3D Cell Culture Market, By End User
6.1 Introduction
6.2 Biotechnology and Pharmaceutical Companies
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Research Laboratories and Institutes
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Other End Users
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. 3D Cell Culture Market, By Product
7.1 Introduction
7.2 Scaffold-Free 3D Cell Cultures
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Microchips
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Scaffold-Based 3D Cell Cultures
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Others
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. 3D Cell Culture Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America 3D Cell Culture, By Application
8.2.2 North America 3D Cell Culture, By End User
8.2.3 North America 3D Cell Culture, By Product
8.3 Europe
8.3.1 Europe 3D Cell Culture, By Application
8.3.2 Europe 3D Cell Culture, By End User
8.3.3 Europe 3D Cell Culture, By Product
8.4 Asia-Pacific
8.4.1 Asia-Pacific 3D Cell Culture, By Application
8.4.2 Asia-Pacific 3D Cell Culture, By End User
8.4.3 Asia-Pacific 3D Cell Culture, By Product
8.5 Rest of the World
8.5.1 Rest of the World 3D Cell Culture, By Application
8.5.2 Rest of the World 3D Cell Culture, By End User
8.5.3 Rest of the World 3D Cell Culture, By Product
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Kirkstall, LTD.
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Mimetas BV
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Tissuse GmbH
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Synthecon Incorporated
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 QGEL SA
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Thermo Fisher Scientific
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Corning Incorporated
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Lonza Group
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Reprocell
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
10.11 3D Biotek LLC
10.11.1 Company Overview
10.11.2 Product/Service Landscape
10.11.3 Financial Overview
10.11.4 Recent Developments
10.12 Emulate, Inc.
10.12.1 Company Overview
10.12.2 Product/Service Landscape
10.12.3 Financial Overview
10.12.4 Recent Developments
10.13 CN Bio Innovations Limited
10.13.1 Company Overview
10.13.2 Product/Service Landscape
10.13.3 Financial Overview
10.13.4 Recent Developments
10.14 Hamilton Company
10.14.1 Company Overview
10.14.2 Product/Service Landscape
10.14.3 Financial Overview
10.14.4 Recent Developments
10.15 Insphero AG
10.15.1 Company Overview
10.15.2 Product/Service Landscape
10.15.3 Financial Overview
10.15.4 Recent Developments
The 3D Cell Culture Market has been segmented as below:
3D Cell Culture Market, By Application
- Clinical Applications
- Tissue Engineering
- Drug Discovery
- Other Applications
3D Cell Culture Market, By End User
- Biotechnology and Pharmaceutical Companies
- Research Laboratories and Institutes
- Other End Users
3D Cell Culture Market, By Product
- Scaffold-Free 3D Cell Cultures
- 3D Bioreactors
- Others
- Microchips
- Scaffold-Based 3D Cell Cultures
- Hydrogels/ECM Analogs
- Others
- Others
3D Cell Culture Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
3D Cell Culture Market, By Company
- Kirkstall, LTD.
- Mimetas BV
- Tissuse GmbH
- Synthecon Incorporated
- QGEL SA
- Thermo Fisher Scientific
- Corning Incorporated
- Merck KGaA
- Lonza Group
- Reprocell
- 3D Biotek LLC
- Emulate, Inc.
- CN Bio Innovations Limited
- Hamilton Company
- Insphero AG
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of 3D Cell Culture market?
The market is expected to grow at a CAGR of 15.5% during the study period (2023-2028)
How big is the 3D Cell Culture market value?
The global 3D cell culture market size is projected to reach USD 2773 million in 2028
What is the segment’s covered for the 3D Cell Culture market?
The segment included in the 3D Cell Culture market is Application, End User, Product, Company and region.
Who are the major key vendors in the 3D Cell Culture market?
Some key players operating in the 3D Cell Culture market include Kirkstall, LTD., Mimetas BV, Tissuse GmbH, Synthecon Incorporated, QGEL SA, Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE